Marginal zone B lymphocytes and blood borne pathogens
Marginal zone B lymphocytes and blood borne pathogens
批准号:
6721313
负责人:
SHIV Subramaniam PILLAI
金额:
$28.96万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2005-03-31
关键词:
B lymphocyteBacillus anthracisBacillus subtilisT lymphocyteanthraxantibody specificityantigen presentationbacteria infection mechanismbacterial antigensbactericidal immunitybioterrorism /chemical warfarechimeric proteinsenzyme linked immunosorbent assaygene targetinggenetically modified animalshemotoxinhost organism interactionhumoral immunitylaboratory mouselysozymepolyglutamatespolymerase chain reactionpulmonary respirationvirulence
中文摘要
全面吸入性炭疽病发展的一个主要阶段是出现压倒性的菌血症。对血液传播的抗原提供保护的一种突出的细胞类型是边缘带B细胞。我们将尝试以聚谷氨酸胶囊和炭疽菌对边缘区B细胞的保护性抗原为靶点,在我们拟议的研究中,我们将使用突变小鼠来评估MZ B细胞在针对血源性抗原的保护性反应中的作用。我们将询问,聚谷氨酸胶囊是否可以通过尝试将其靶向于MZ B细胞,或者通过将其作为多价抗原保持构象来实现免疫原性。我们还将检查对PA的免疫反应是否可以
通过产生PA-C3d融合蛋白或使用PA-多糖偶联物试图将其重定向到MZ B细胞而增强。然后,我们将讨论一些抗原-C3d融合成功的原因是否因为抗原针对MZ B细胞,使用溶菌酶特异性B细胞和溶菌酶-C3d融合蛋白作为模型系统。我们将使用溶菌酶特异的MZ B细胞来尝试询问除了抗原本身之外,启动抗原特异的MZ B细胞的增殖需要什么。最后,我们将尝试确定抗原特异性的MZ B细胞,而不是毛囊B细胞,是否能够容易地捕获和呈递血液传播的抗原,从而激活原始T细胞。
英文摘要
A major stage in the development of full-blown inhalation anthrax is the development of overwhelming bacteremia. A prominent cell type that provides protection against blood borne antigens is the marginal zone B cell. Attempts will be made to target the polyglutamate capsule and the protective antigen of anthrax to marginal zone B cells, in our proposed studies we will use mutant mice in an attempt to evaluate the role of MZ B cells in protective responses against blood-borne antigens. We will ask whether the polyglutamate capsule can be rendered immunogenic either by attempting to target it to MZ B cells, or by preserving it conformationally as a multivalent antigen. We will also examine whether the immune response to PA can be
enhanced by generating a PA-C3d fusion protein or by using a PA-polysaccharide conjugate in an attempt to redirect it to MZ B cells. We will then address the general issue as to whether the reason why some antigen-C3d fusions have been successful is because the antigen was targeted to MZ B cells, using lysozyme specific B cells and lysozyme-C3d fusion proteins as a model system. We will use lysozyme-specific MZ B cells to attempt to ask what is required beyond antigen per se to initiate proliferation of antigen-specific MZ B cells. Finally we will attempt to determine whether antigen-specific MZ B cells, as opposed to follicuar B cells, can readily capture and present blood borne antigens, and thus activate na'fve T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program in Immunological Tolerance and Autoimmunity
-
批准号:9102896
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2015
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Training Program in Immunological Tolerance and Autoimmunity
-
批准号:9264976
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2015
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Training Program in Immunological Tolerance and Autoimmunity
-
批准号:8933644
-
项目类别:
-
资助金额:$18.55万
-
财政年份:2015
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An Autoimmune center of excellence for the study of IgG4-related disease
-
批准号:8680709
-
项目类别:
-
资助金额:$71.29万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Coordinating an ACE studying IgG4-related diseases
-
批准号:10188398
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Admin-Core-001
-
批准号:10794460
-
项目类别:
-
资助金额:$63.89万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An autoimmune center of excellence for the study of IgG4-related disease
-
批准号:9915860
-
项目类别:
-
资助金额:$44.9万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Studies on the Immunology of IgG4-related diseases
-
批准号:8732923
-
项目类别:
-
资助金额:$36.12万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Coordinating an ACE studying IgG4-related diseases
-
批准号:10394915
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An autoimmune center of excellence for the study of IgG4-related disease
-
批准号:10188397
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An autoimmune center of excellence for the study of IgG4-related disease
-
批准号:10394914
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Cytotoxic CD4+ T cells and autoimmune fibrotic disorders
-
批准号:10188399
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Cytotoxic CD4+ T cells and autoimmune fibrotic disorders
-
批准号:10394916
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
An autoimmune center of excellence for the study of IgG4-related disease
-
批准号:10609833
-
项目类别:
-
资助金额:$63.89万
-
财政年份:2014
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Inducing neutralizing antibodies to HIV by inhibiting SIAE
-
批准号:8291408
-
项目类别:
-
资助金额:$90.46万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Mutations in the SIAE Gene and Susceptibility to Autoimmune Diseases
-
批准号:8070140
-
项目类别:
-
资助金额:$2.87万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Inducing neutralizing antibodies to HIV by inhibiting SIAE
-
批准号:8473774
-
项目类别:
-
资助金额:$55.71万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Inducing neutralizing antibodies to HIV by inhibiting SIAE
-
批准号:8089346
-
项目类别:
-
资助金额:$67.15万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Human Memory B cells in Humanized Mice
-
批准号:7876327
-
项目类别:
-
资助金额:$26.55万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
Human Memory B cells in Humanized Mice
-
批准号:8103171
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2010
-
负责人:SHIV Subramaniam PILLAI
-
依托单位:
海外基金